Cancer Immunotherapy MSc

Reino Unido

5

1

¿Qué aprenderé?

Why study this course?

Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.

More about this course

The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.

You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.

The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Where this course can take you

As a graduate of this course, you’ll be well prepared to work for companies that are developing cancer immunotherapies. Such companies include global biopharmaceutical company Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an an ever-growing number of start-up companies that are tackling cancer, including Vyriad, UNUM Therapeutics and Alpine Immune Sciences.

You’ll also have ample opportunity for future postgraduate study within the School of Human Sciences and the Cellular and Molecular Immunology Research Centre at the MPhil/PhD level, as well as research opportunities with partners within the UK, Europe and the rest of the world.

¿En cuál departamento estoy?

School of Human Sciences

Opciones de estudio

a tiempo completo (1 )

Costos de estudio
£18.150,00 (US$ 22.858) por año
Esta es una tarifa fija

*El precio que se muestra es una referencia, por favor verificar con la institución

Fecha de inicio

23 Septiembre 2024

Lugar

Holloway

166-220 Holloway Road,

Islington,

N7 8DB, England

Requerimiento de entrada

Para estudiantes internacionales

You will be required to have: at least a lower second (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis). Academic IELTS: Overall score required: 6.0; Component scores required: Listening: 5.5; Reading: 5.5; Writing: 5.5; Speaking: 5.5. Test of English as a Foreign Language Internet Based Test (TOEFL iBT): Overall score required: 72; Component scores required: Listening: 17; Reading: 18; Writing: 17; Speaking: 20.

Puede haber diferentes requisitos de IELTS en función del curso elegido.

AÑADIR A MIS FAVORITOS

Acerca de London Metropolitan University

Atrayendo a personas de todas partes del mundo, London Met alberga una comunidad estudiantil de todo tipo de orígenes.

  • Top 10 en Experiencia Estudiantil (Good University Guide 2024)
  • Top 10 por Calidad Docente (Good University Guide 2024)
  • Estudia en el corazón de The Real London
  • Únete a la comunidad estudiantil con más de 140 nacionalidades

Ponte en contacto